Erratum to: Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor

被引：0
|
作者：
Henri Bounameaux
A. John Camm
机构：
[1] University Hospital of Geneva,Department of Internal Medicine
[2] University Medical Center (CMU),Faculty of Medicine, Dean’s Office
[3] St George’s University of London,Division of Clinical Sciences
来源：
Drugs | 2014年 / 74卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1455 / 1455
相关论文
共 50 条
  • [21] RIVAROXABAN, A DIRECT FACTOR XA INHIBITOR: A DRUG UPDATE
    Shyamasakhi, P. D.
    Sania, K. M.
    Meena, N. D.
    Bikram, T.
    Tarinita, L.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2015, 6 (08): : 3186 - 3191
  • [22] EFFECT OF NAPROXEN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EDOXABAN, AN ORAL FACTOR Xa INHIBITOR.
    Mendell-Harary, J.
    Chen, S.
    Noveck, R. J.
    Lee, F.
    Petrushun, V.
    Shi, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S63 - S63
  • [23] The edoxaban, a new oral direct and specific anti-Xa anticoagulant
    Chleir, F.
    PHLEBOLOGIE-ANNALES VASCULAIRES, 2011, 64 (04): : 73 - 73
  • [24] Edoxaban, an oral direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro
    Morishima, Y.
    Honda, Y.
    Kamisato, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 688 - 688
  • [25] Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancer
    Ikeda, Satoshi
    Koga, Seiji
    Yamagata, Yuki
    Eguchi, Masamichi
    Sato, Daisuke
    Muroya, Takahiro
    Yonekura, Tsuyoshi
    Tsuneto, Akira
    Yoshimuta, Tsuyoshi
    Koide, Yuji
    Kawano, Hiroaki
    Maemura, Koji
    JOURNAL OF CARDIOLOGY, 2018, 72 (1-2) : 120 - 127
  • [26] Pharmacokinetics of the Direct Factor Xa Inhibitor Edoxaban and Digoxin Administered Alone and in Combination
    Mendell, Jeanne
    Noveck, Robert J.
    Shi, Minggao
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (04) : 335 - 341
  • [27] Evaluation of the oral direct factor Xa inhibitor - betrixaban
    Palladino, Michael
    Merli, Geno
    Thomson, Lynda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (11) : 1465 - 1472
  • [28] Apixaban: an Oral Direct Factor-Xa Inhibitor
    Jimenez, David
    Yusen, Roger D.
    Ramacciotti, Eduardo
    ADVANCES IN THERAPY, 2012, 29 (03) : 187 - 201
  • [29] Apixaban: an Oral Direct Factor-Xa Inhibitor
    David Jiménez
    Roger D. Yusen
    Eduardo Ramacciotti
    Advances in Therapy, 2012, 29 : 187 - 201
  • [30] Apixaban, an oral, direct inhibitor of activated Factor Xa
    Shantsila, Eduard
    Lip, Gregory Y. H.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (09) : 1020 - 1033
12345